Zen Graphene Solutions develops graphene-based potential treatment for bacterial and viral Infections

ZEN Graphene Solutions has announced that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound.

Recent testing results from the University Health Network/Mount Sinai Hospital Department of Microbiology in Toronto are said to indicate that this patent pending formulation could be a medical breakthrough in the treatment of numerous human-contracted pathogens including upper and lower respiratory tract infections – where COVID-19 is a major contributor – as well as drug resistant organisms.